The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis

BACKGROUND: Use of the Xpert MTB/RIF assay has increased the number of people diagnosed with rifampicin-resistant tuberculosis (RR-TB), especially in South Africa where Xpert is now the initial diagnostic for individuals with TB symptoms. We hypothesized that a proportion of RR-TB patients determine...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Antimicrob Chemother
Päätekijät: Whitfield, Michael G, Warren, Robin M, Mathys, Vanessa, Scott, Lesley, De Vos, Elise, Stevens, Wendy, Streicher, Elizabeth M, Groenen, Guido, Sirgel, Frederick A, Van Rie, Annelies
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6148329/
https://ncbi.nlm.nih.gov/pubmed/29982641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky248
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia